Pharmaceuticals

Endocrinology Drugs Market Forecast: What to Expect by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Endocrinology Drugs Market Between 2025 And 2029?

The endocrinology drugs market size has experienced a slight reduction in recent years. This market is projected to shift from $26.29 billion in 2024 to $26.2 billion in 2025, reflecting a compound annual growth rate (CAGR) of -0.3%. During the historical period, its expansion was fueled by factors such as increasing prevalence of diabetes globally, increasing government initiatives, increasing healthcare expenditure, increasing prevalence of adrenal gland disorders, a rise in demand for insulin analogs, and growth in the number of endocrinologists.

The endocrinology drugs market size is anticipated to experience slight expansion in the coming years. It is projected to reach “$26.37 billion by 2029, growing at a compound annual growth rate (CAGR) of 0.2%. This growth during the forecast period is attributable to an expanding diabetic population, the increasing prevalence of endocrine disorders, a rising number of adolescents with hormonal imbalances, and escalating obesity rates. Significant trends for the forecast period include technological advancements, the adoption of advanced drug delivery systems, the integration of digital health solutions, precision medicine, and combination therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20769&type=smp

What Are The Key Drivers Of Growth In The Endocrinology Drugs Market?

The increasing occurrence of endocrine diseases is projected to drive expansion within the endocrinology drugs market in the future. Endocrine diseases are conditions affecting the endocrine system, leading to disruptions in hormone production or regulation that can hinder normal bodily functions. This growing prevalence of endocrine disorders stems from various elements such as shifts in lifestyle, an aging demographic, and enhanced diagnostic capabilities, all of which have contributed to their heightened identification and occurrence. Endocrinology medications assist in managing these conditions by adjusting hormone levels, treating glandular issues, and re-establishing hormonal equilibrium to lessen symptoms and improve general health. For example, in May 2023, the National Library of Medicine, a US-based medical library, reported that about 13 million people in the United States, representing 4.78% of the population, are afflicted with undiagnosed endocrine disorders. Among these, thyroid disease stands out as a highly common endocrine ailment, making up around 30% to 40% of individuals seen in endocrine practices. Consequently, the increasing prevalence of endocrine diseases is fostering growth in the endocrinology drugs market.

How Is The Endocrinology Drugs Market Classified Into Different Segments?

The endocrinology drugs market covered in this report is segmented –

1) By Indication: Hyperthyroidism, Hypothyroidism, Diabetes, Polycystic Ovarian Syndrome, Growth Hormone Disorders, Pituitary Gland Disorders, Other Indications

2) By Therapy Area: Diabetes Drugs, Thyroid Hormone Disorder Drugs, Human Growth Hormone, Testosterone Replacement Therapy, Others Therapy Areas

3) By Distribution Channel: Hospital pharmacies, Online Pharmacies, Retail pharmacies

4) By End User: Hospitals, Ambulatory Surgical Centers, Others End Users

Subsegments:

1) By Hyperthyroidism: Antithyroid Medications, Radioactive Iodine Therapy, Beta Blockers

2) By Hypothyroidism: Levothyroxine-based Medications, Liothyronine-based Medications, Combination Hormonal Therapies

3) By Diabetes: Insulin Therapies, Oral Antidiabetic Drugs (OADs), GLP-1 Receptor Agonists, SGLT-2 Inhibitors, DPP-4 Inhibitors

4) By Polycystic Ovarian Syndrome (PCOS): Oral Contraceptives, Metformin, Clomiphene Citrate, Anti-Androgens

5) By Growth Hormone Disorders: Recombinant Human Growth Hormone (rhGH), Growth Hormone Secretagogues, Growth Hormone Receptor Antagonists

6) By Pituitary Gland Disorders: Somatostatin Analogs, Gonadotropins, Dopamine Agonists

7) By Other Indications: Adrenal Gland Disorders, Osteoporosis, Parathyroid Disorders, Male Hormonal Imbalances

Which Key Trends Are Expected To Influence The Endocrinology Drugs Market In The Coming Years?

Leading companies operating within the endocrinology drugs market are increasingly focusing on the development of innovative products, such as ready-to-use vials, to enhance the administration of medications. These ready-to-use vials are medication containers that come pre-filled and pre-dosed, requiring no reconstitution or other preparation before being administered. For instance, in December 2022, Hikma Pharmaceuticals plc, a pharmaceutical company based in the UK, launched Levothyroxine sodium injection in ready-to-use vials with a concentration of 100 mcg/mL. This formulation is engineered for immediate application, eliminating the necessity for reconstitution and diminishing the potential for errors during preparation, which consequently elevates patient safety. It delivers precise and consistent dosing, a vital feature for managing conditions like hypothyroidism and myxedema coma. Additionally, these ready-to-use vials improve the operational efficiency for healthcare providers, saving time and ensuring accurate administration in critical care settings.

Which Leading Players Are Enhancing Their Endocrinology Drugs Market Presence Worldwide?

Major companies operating in the endocrinology drugs market are Johnson & Johnson Inc., Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Novartis International AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Biocon Limited, Boehringer Ingelheim International GmbH, Mylan N.V., Sandoz International GmbH, Ipsen Pharma, Ferring Pharmaceuticals Inc., Endocrine Pharma Private Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/endocrinology-drugs-global-market-report

How Does The Endocrinology Drugs Market Perform Across Key Geographic Regions?

North America was the largest region in the endocrinology drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrinology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Endocrinology Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20769&type=smp

Browse Through More Reports Similar to the Global Endocrinology Drugs Market 2025, By The Business Research Company

Radiopharmaceuticals Global Market 2025

https://www.thebusinessresearchcompany.com/report/radiopharmaceuticals-global-market

Pancreatic Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Pancreatic Cancer Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795